Boston Scientific Operating Income Over Time
| BSX Stock | USD 77.64 2.14 2.83% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Boston Scientific Performance and Boston Scientific Correlation. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. Projected growth potential of Boston fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Boston Scientific assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 0.6 | Earnings Share 1.54 | Revenue Per Share | Quarterly Revenue Growth 0.203 | Return On Assets |
Investors evaluate Boston Scientific Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Boston Scientific's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Boston Scientific's market price to deviate significantly from intrinsic value.
It's important to distinguish between Boston Scientific's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Boston Scientific should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Boston Scientific's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Boston Scientific Corp and related stocks such as Stryker, Medtronic PLC, and Danaher Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SYK | 14.6 M | 2 B | 1.9 B | 2.1 B | 2.2 B | 2.3 B | 2.6 B | 2.8 B | 3.1 B | 3.4 B | 3 B | 3.8 B | 3.7 B | 4.3 B | 5.1 B | 5.6 B | 5.9 B |
| MDT | 76.3 M | 4.5 B | 4.4 B | 3.8 B | 3.8 B | 5.4 B | 5.4 B | 6.6 B | 6.3 B | 4.8 B | 4.5 B | 5.8 B | 5.5 B | 5.1 B | 6 B | 6.8 B | 7.2 B |
| DHR | 19.9 M | 2.7 B | 3.2 B | 3.4 B | 3.6 B | 2.4 B | 3 B | 3.1 B | 3.1 B | 3.4 B | 4.3 B | 8.1 B | 7.5 B | 5.2 B | 5.2 B | 5.1 B | 5.4 B |
| GILD | (4.8 M) | 3.8 B | 4 B | 4.5 B | 15.3 B | 22.2 B | 17.6 B | 14.1 B | 8.2 B | 4.3 B | 4.1 B | 9.9 B | 7.3 B | 7.6 B | 1.7 B | 1.9 B | 1.8 B |
| PFE | 880 M | 18.4 B | 18 B | 16.9 B | 14 B | 13.3 B | 14.3 B | 14.4 B | 15.3 B | 7.5 B | 9.1 B | 20.8 B | 37.5 B | 5.3 B | 16.5 B | 15.4 B | 11.2 B |
| AMGN | (900 K) | 4.3 B | 5.6 B | 5.9 B | 6.2 B | 8.5 B | 9.8 B | 10 B | 10.3 B | 9.7 B | 9.1 B | 7.6 B | 9.6 B | 7.9 B | 7.3 B | 14.9 B | 15.6 B |
| ABT | 737.1 M | 6.8 B | 2 B | 2.1 B | 2.9 B | 2.9 B | 3.2 B | 2 B | 3.8 B | 4.6 B | 5.3 B | 9.2 B | 8.4 B | 6.4 B | 6.8 B | 8 B | 4.1 B |
| SNY | 971 M | 5.9 B | 6.4 B | 5 B | 6.1 B | 5.6 B | 6.5 B | 5.8 B | 4.7 B | 3.1 B | 14.1 B | 8.1 B | 10.2 B | 7 B | 7.3 B | 6.3 B | 6.1 B |
| MCK | (30.1 M) | 2.4 B | 2.4 B | 2.6 B | 3.5 B | 3.9 B | 3.4 B | 2.9 B | 3.1 B | 3 B | 3.5 B | 2.7 B | 4.5 B | 3.9 B | 4.4 B | 5 B | 5.3 B |
Boston Scientific Corp and related stocks such as Stryker, Medtronic PLC, and Danaher Operating Income description
Operating Income is the amount of profit realized from Boston Scientific Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Boston Scientific Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Boston Scientific Corp | BSX |
| Classification | Healthcare |
| Business Address | 300 Boston Scientific |
| Exchange | New York Stock Exchange |
USD 77.64
Additional Tools for Boston Stock Analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.